In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinones

Free Radical Biology and Medicine

Volumn 89, Issue , 2015, Pages 126-134

  Cassagnes, Laure Estelle ^a   Perio, Pierre ^a   Ferry, Gilles ^b   Moulharat, Natacha ^b   Antoine, Mathias ^b   Gayon, Régis ^c   Boutin, Jean A ^b   Nepveu, Françoise ^a   Reybier, Karine ^a  

^a UMR 152 IRD Universite Paul Sabatier   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c Vectalys SAS CanalBiotech II   (France)

Author keywords

EPR; Free radicals; NQO1; NQO2; Ortho quinones; Oxidative stress; Para quinones; Quinone reductase; Reactive oxygen species

Indexed keywords

3,5 DI TERT BUTYL O BENZOQUINONE; ADRENOCHROME; AMINOCHROME; DOPACHROME; HYDROQUINONE DERIVATIVE; MENADIONE; QUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG; BENZOQUINONE; BENZOQUINONE DERIVATIVE; FREE RADICAL; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CELL LEVEL; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FEMALE; MONITORING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CHEMISTRY; CHO CELL LINE; CRICETULUS; HAMSTER; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; BENZOQUINONES; CHO CELLS; CRICETINAE; CRICETULUS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; OXIDATION-REDUCTION; OXYGEN; QUINONE REDUCTASES; REACTIVE OXYGEN SPECIES;

EID: 84942421159     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.07.150     Document Type: Article

References (50)

1. R. Venugopal, P. Joseph, and A.K. Jaiswal Gene expression of DT-diaphorase in cancer cells J.F. Henry, C. Enrique, Oxidative Stress and Signal Transduction 1997 Chapman & Hall New York 441 475
2. P. Talalay, J.W. Fahey, W.D. Holtzclaw, T. Prestera, and Y. Zhang Chemoprotection against cancer by phase 2 enzyme induction Toxicol. Lett. 82-83 1995 173 179
3. R.J. Riley, and P. Workman DT-diaphorase and cancer chemotherapy Biochem. Pharmacol. 43 1992 1657 1669
4. I.I.D.J. Long, and A.K. Jaiswal Mouse NRH:quinone oxidoreductase (NQO2): cloning of cDNA and gene- and tissue-specific expression Gene 252 2000 107 117
5. R. Li, M.A. Bianchet, P. Talalay, and L.M. Amzel The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction Proc. Natl. Acad. Sci. USA 92 1995 8846 8850
6. C.E. Foster, M.A. Bianchet, P. Talalay, Q. Zhao, and L.M. Amzel Crystal structure of human quinone reductase type 2, a metalloflavoprotein Biochemistry 38 1999 9881 9886
7. K. Wu, R. Knox, X.Z. Sun, P. Joseph, A.K. Jaiswal, D. Zhang, P.S. Deng, and S. Chen Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase Arch. Biochem. Biophys. 347 1997 221 228
8. F. Vella, G. Ferry, P. Delagrange, and J.A. Boutin NRH:quinone reductase 2: an enzyme of surprises and mysteries Biochem. Pharmacol. 71 2005 1 12
9. G. Ferry, S. Hecht, S. Berger, N. Moulharat, F. Coge, G. Guillaumet, V. Leclerc, S. Yous, P. Delagrange, and J.A. Boutin Old and new inhibitors of quinone reductase 2 Chem. Biol. Interact. 186 2010 103 109
10. J.A. Boutin, F. Chatelain-Egger, F. Vella, P. Delagrange, and G. Ferry Quinone reductase 2 substrate specificity and inhibition pharmacology Chem. Biol. Interact. 151 2005 213 228
11. E. Janda, M. Parafati, S. Aprigliano, C. Carresi, V. Visalli, I. Sacco, D. Ventrice, T. Mega, N. Vadalá, S. Rinaldi, V. Musolino, E. Palma, S. Gratteri, D. Rotiroti, and V. Mollace The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo Br. J. Pharmacol. 168 2013 46 59
12. S.D. Pegan, M. Sturdy, G. Ferry, P. Delagrange, J.A. Boutin, and A.D. Mesecar X-ray structural studies of quinone reductase 2 nanomolar range inhibitors Protein Sci. 20 2011 1182 1195
13. E. Bergamaschi, G. De Palma, P. Mozzoni, S. Vanni, M.V. Vettori, F. Broeckaert, A. Bernard, and A. Mutti Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects Am. J. Respir. Crit. Care Med. 163 2001 1426 1431
14. J.H. Zhang, Y. Li, R. Wang, H. Geddert, W. Guo, D.G. Wen, Z.F. Chen, L.Z. Wei, G. Kuang, M. He, L.W. Zhang, M.L. Wu, and S.J. Wang NQO1 C609T polymorphism associated with esophageal and gastric cardiac carcinoma in North China World J. Gastroenterol. 9 2003 1390 1393
15. W. Wang, W.D. Le, T. Pan, J.L. Stringer, and A.K. Jaiswal Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease J. Gerontol. A Biol. Sci. Med. Sci 63 2008 127 134
16. S. Harada, H. Tachikawa, and Y. Kawanishi A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia Psychiatr. Genet. 13 2003 205 209
17. T. Okubo, S. Harada, S. Higuchi, and S. Matsushita Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms Alcohol Clin. Exp. Res. 27 2003 68 71
18. H. Kappus, and H. Sies Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation Experientia 37 1981 1233 1241
19. J.L. Bolton, M.A. Trush, T.M. Penning, G. Dryhurst, and T.J. Monks Role of quinones in toxicology Chem. Res. Toxicol. 13 2000 135 160
20. B. Testa The Metabolism of Drugs and Other Xenobiotics: Biochemistry of Redox Reactions 1995 Academic Press New York
21. J. Smythies, and L. Galzigna The oxidative metabolism of catecholamines in the brain: a review Biochim. Biophys. Acta 1380 1998 159 162
22. E.L. Cavalieri, and E.G. Rogan A unifying mechanism in the initiation of cancer and other diseases by catechol quinones Ann. N. Y. Acad. Sci. 1028 2004 247 257
23. K. Reybier, P. Perio, G. Ferry, J. Bouajila, P. Delagrange, J.A. Boutin, and F. Nepveu Insights into the redox cycle of human quinone reductase 2 Free. Radic. Res. 45 2011 1184 1195
24. N.W. Gaikwad, L. Yang, E.G. Rogan, and E.L. Cavalieri Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones Free Radic. Biol. Med. 46 2009 253 262
25. R. Graumann, I. Paris, P. Martinez-Alvarado, P. Rumanque, C. Perez-Pastene, S.P. Cardenas, P. Marin, F. Diaz-Grez, R. Caviedes, P. Caviedes, and J. Segura-Aguilar Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease: possible neuroprotective role of DT-diaphorase Pol. J. Pharmacol 54 2002 573 579
26. Y. Fu, L. Buryanovskyy, and Z. Zhang Quinone reductase 2 is a catechol quinone reductase J. Biol. Chem. 283 2008 23829 23835
27. L.F.S. Sampaio, F.P. Mesquita, P.R. de Sousa, J.L. Silva, and C.N. Alves The melatonin analog 5-MCA-NAT increases endogenous dopamine levels by binding NRH:quinone reductase enzyme in the developing chick retina Int. J. Dev. Neurosci. 38 2014 119 126
28. J.A. Boutin Camphoroquinone reduction: another reaction catalyzed by rat liver cytosol 3 alpha-hydroxysteroid dehydrogenase Biochim. Biophys. Acta 870 1986 463 472
29. C.E. Benoit, W.B. Rowe, C. Menard, P. Sarret, and R. Quirion Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory Trends Pharmacol. Sci. 32 2011 43 52
30. F. Mailliet, G. Ferry, F. Vella, S. Berger, F. Coge, P. Chomarat, C. Mallet, S.P. Guenin, G. Guillaumet, M.C. Viaud-Massuard, S. Yous, P. Delagrange, and J.A. Boutin Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme Biochem. Pharmacol. 71 2005 74 88
31. R.D. Bongard, B.J. Lindemer, G.S. Krenz, and M.P. Merker Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells Free Radic. Biol. Med. 46 2009 25 32
32. M. AbuKhader, J. Heap, C. De Matteis, B. Kellam, S.W. Doughty, N. Minton, and M. Paoli Binding of the anticancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex J. Med. Chem. 347 1997 221 228
33. R.J. Knox, T.C. Jenkins, S.M. Hobbs, S. Chen, R.G. Melton, and P.J. Burke Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy Cancer Res 60 2000 4179 4186
34. M.R. Middleton, R. Knox, E. Cattell, U. Oppermann, R. Midgley, R. Ali, T. Auton, R. Agarwal, D. Anderson, D. Sarker, I. Judson, T. Osawa, V.J. Spanswick, S. Davies, and D. Kerr Quinone oxidoreductase-2-mediated prodrug cancer therapy Sci. Transl. Med 2 2010 40 50
35. G.M. Rosen, and B.A. Freeman Detection of superoxide generated by endothelial cells Proc. Natl. Acad. Sci. USA 81 1984 7269 7273
36. T. Nishiyama, T. Izawa, M. Usami, T. Ohnuma, K. Ogura, and A. Hiratsuka UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation Biochem. Biophys. Res. Commun. 394 2010 459 463
37. T. Nishiyama, T. Izawa, M. Usami, T. Ohnuma, K. Ogura, and A. Hiratsuka Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells Biochem. Biophys. Res. Commun. 394 2010 459 463
38. K. Ranguelova, A.B. Rice, A. Khajo, M. Triquigneaux, S. Garantziotis, R.S. Magliozzo, and R.P. Mason Formation of reactive sulfite-derived free radicals by the activation of human neutrophils: an ESR study Free Radic. Biol. Med. 52 2012 1264 1271
39. A. Samuni, A.J. Carmichael, A. Russo, J.B. Mitchell, and P. Riesz On the spin trapping and ESR detection of oxygen-derived radicals generated inside cells Proc. Natl. Acad. Sci. USA 83 1986 7593 7597
40. J.A. DeGray, D.N.R. Rao, and R.P. Mason Reduction of paraquat and related bipyridylium compounds to free radical metabolites by rat hepatocytes Arch. Biochem. Biophys. 289 1991 145 152
41. B. Kalyanaraman, V. Darley-Usmar, K.J.A. Davies, P.A. Dennery, H.J. Forman, M.B. Grisham, G.E. Mann, K. Moore, I.I.L.J. Roberts, and H. Ischiropoulos Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations Free Radic. Biol. Med. 52 2012 1 6
42. J. Segura-Aguilar, D. Metodiewa, and C.J. Welch Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects Biochim. Biophys. Acta 1381 1998 1 6
43. C. Arriagada, I. Paris, de las Matas M.J. Sanchez, P. Martinez-Alvarado, S. Cardenas, P. Castañeda, R. Graumann, C. Perez-Pastene, C. Olea-Azar, E. Couve, M.T. Herrero, P. Caviedes, and J. Segura-Aguilar On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation Neurobiol. Dis. 16 2004 468 477
44. J. Segura-Aguilar, D. Metodiewa, and S. Baez The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system Neurotox. Res. 3 2001 157 165
45. S. Baez, and J. Segura Aguilar Effects of superoxide dismutase and catalase during reduction of adrenochrome by DT-diaphorase and NADPH-cytochrome P450 reductase Biochem. Mol. Med. 56 1995 37 44
46. A. Bindoli, M.P. Rigobello, and L. Galzigna Reduction of adrenochrome by rat liver and brain DT-diaphorase Free Radic. Res. Commun. 8 1990 295 298
47. H.R. Kucera, M. Livingstone, C.G. Moscoso, and N.W. Gaikwad Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides Free Radic. Res. 47 2013 1016 1026
48. J. Taskinen, B.T. Ethell, P. Pihlavisto, A.M. Hood, B. Burchell, and M.W.H. Coughtrie Conjugation of catechols by recombinant human sulfotransferases, UDP-glucuronosyltransferases, and soluble catechol o-methyltransferase: structure-conjugation relationships and predictive models Drug Metab. Dispos. 31 2003 1187 1197
49. B. Kalyanaraman, C.C. Felix, and R.C. Sealy Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes Environ. Health Perspect. 64 1985 185 198
50. C.E. Benoit, S. Bastianetto, J. Brouillette, Y. Tse, J.A. Boutin, P. Delagrange, T. Wong, P. Sarret, and R. Quirion Loss of quinone reductase 2 function selectively facilitates learning behaviors J. Neurosci. 30 2010 12690 12700